breast cancer - HR positive | |
la/mBC - HR positive - (neo)adjuvant (NA) | |
buparlisib plus letrozole | NEO-ORB ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -